(lp0
S'Marsh &amp; McLennan Companies Reaches Analyst Target Price Nasdaq - Mar 20, 2017 In recent trading, shares of Marsh &amp; McLennan Companies Inc.  have crossed above the average analyst 12-month target price of $74.75, changing hands for $75.14/share.'
p1
aS"Marsh &amp; McLennan Companies'  CEO Dan Glaser on Q4 2016 Results - Earnings ... Seeking Alpha - Feb 2, 2017 Welcome to the Marsh &amp; McLennan Companies' Conference Call. Today's call is being recorded. Fourth quarter 2016 financial results and supplemental information were issued earlier this morning.Marsh &amp; McLennan Companies' net income up 16% in Q4 2016 to US$436 million - Canadian UnderwriterMarsh &amp; McLennan  Surpasses Q4 Earnings Estimates - Nasdaq"
p2
aS'Marsh &amp; McLennan Companies, Inc.  Given Average Rating of Buy by Brokerages The Cerbat Gem - 10 hours ago Marsh &amp; McLennan Companies logo Marsh &amp; McLennan Companies, Inc.  has been given an average recommendation of Buy by the fourteen brokerages that are covering the stock.The Federated Investors Inc. PA Decreases Position in Marsh &amp; McLennan ... - Petro Global News 24How has Marsh &amp; McLennan Companies, Inc. performed recently? - The Daily Leicester'
p3
aS'Marsh &amp; McLennan Companies Names Susan A. Stone General Counsel of Risk and ... Business Wire  - Jan 18, 2017 NEW YORK----Marsh &amp; McLennan Companies, Inc. , a global professional services firm offering clients advice and solutions in risk, strategy and people, announced today that Susan A. Stone has been appointed General&nbsp;...Marsh &amp; McLennan  Unit to Buy J. Smith Lanier &amp; Co. - NasdaqCommonwealth Bank of Australia Has $2317000 Position in Marsh &amp; McLennan ... - Sports Perspectives'
p4
aS"Average Brokerage Rating Of Vertex Pharmaceuticals Incorporated , Marsh ... The USA Commerce - Mar 20, 2017 Shares of Vertex Pharmaceuticals Incorporated  dropped -0.48% to $91.92. During the trading on 03/17/2017, Company's stock ranged from $91.76 to $93.50. The relative strength index or RSI highlights overbought  and oversold&nbsp;..."
p5
aS'Marsh &amp; McLennan  Up 6.7% Since Earnings Report: Can It Continue? Yahoo Finance - Mar 6, 2017 It has been about a month since the last earnings report for Marsh &amp; McLennan Companies, Inc. MMC. Shares have added about 6.7% in that time frame, outperforming the market.'
p6
aS'Marsh &amp; McLennan Companies, Inc.  Technicals Are Painting A Bleak Picture USA Commerce Daily - 19 hours ago With all other things going on, Marsh &amp; McLennan Companies, Inc.  has been on a run - rising 9.99 percent in just three months.'
p7
aS"Analytical Guide for Marsh &amp; McLennan Companies, Inc. , Biogen Inc. (BIIB ... The USA Commerce - Mar 16, 2017 Shares of Marsh &amp; McLennan Companies, Inc.  surged 0.13% to $74.35. During the trading on 03/15/2017, Company's stock ranged from $73.88 to $74.55."
p8
aS'Marsh &amp; McLennan Companies, Inc.  held by 133 SEC 13F Filers Post Analyst - Mar 17, 2017 Marsh &amp; McLennan Companies, Inc.  reached 29.82% versus a 1-year low price of $59.11. The stock was last seen 0.44% higher, reaching at $74.68 on Thursday, March 16, 2017.Recent Trading Alert: Marsh &amp; McLennan Companies, Inc.  - Is stories'
p9
aS'Marsh &amp; McLennan Hits 52-Week High on Strong Earnings, Deals Yahoo Finance - Feb 21, 2017 Shares of Marsh &amp; McLennan Companies, Inc. MMC hit a 52-week high of $73.52 on strong fourth-quarter results and recent deals.Analytical Guide for Marsh &amp; McLennan Companies, Inc. , Amgen Inc. (AMGN ... - The USA CommerceRevenue Approximations Analysis: Marsh &amp; McLennan Companies, Inc. (MMC ... - StockNewsJournal'
p10
a.